Filing Details
- Accession Number:
- 0000950170-24-028811
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-08 17:40:40
- Reporting Period:
- 2024-03-06
- Accepted Time:
- 2024-03-08 17:40:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1680367 | Shattuck Labs Inc. | STTK | Pharmaceutical Preparations (2834) | 812575858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1970664 | Stephen Stout | C/O Shattuck Labs, Inc. 500 W. 5Th Street, Suite 1200 Austin TX 78701 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-06 | 4,650 | $3.51 | 83,982 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-06 | 4,650 | $10.53 | 79,332 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-06 | 6,459 | $3.57 | 85,791 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-06 | 6,459 | $10.53 | 79,332 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-06 | 4,895 | $10.53 | 74,437 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-03-06 | 4,650 | $0.00 | 4,650 | $3.51 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-03-06 | 6,459 | $0.00 | 6,459 | $3.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 9,300 | 2032-09-08 | No | 4 | M | Direct | |
| 17,391 | 2033-01-25 | No | 4 | M | Direct |
Footnotes
- Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023.
- The stock option was granted to the Reporting Person on September 8, 2022, one-third of which vested on September 8, 2023 and the remaining two-thirds of which will vest on September 8, 2024.
- The stock option was granted to the Reporting Person on January 25, 2023, one-quarter of which vested on January 10, 2024 and the remaining three-quarters of which will vest in approximately equal monthly installments through January 10, 2027.
Billionaire Hedge Funds
